|
DOSAGE
|
Seasonal Allergic Conjunctivitis: 1 gtt QID for ocular itching
|
|
Post-Op Inflammation (Cataract): 1 gtt QID in operated eye QID (start 24 hrs after surgery) x 2 weeks
|
|
GENERIC
|
ketorolac tromethamin 0.5%
|
|
INDICATIONS
|
ACULAR® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. ACULAR® ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
|
|
MECHANISM OF ACTION
|
NSAID (Non-selective COX inhibitor)
|
|
MICROBIOLOGY
|
Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis.
|
|
CONTRAINDICATIONS & WARNINGS
|
Delayed Healing, Epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation possible in susceptible patients.
|
|
Hypersensitivity to any of the ingredients in the formulation. Possible cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory agents.
|
|
PEDIATRIC USE
|
Safety and efficacy in pediatric patients below the age of 2 have not been established.
|
|
PREGNANCY
|
Category C Teratogenic Effects.. There are no adequate and well-controlled studies in pregnant women. ACULAR® solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
|
|
NOTE
|
Typically used instead of pressure patch and cycloplegia to control pain of corneal abrasion.
|
|
All topical nonsteroidal anti-inflammatory drugs (NSAIDs) may slow or delay healing. Remove Contact lens prior to use
|
